Co-Authors
This is a "connection" page, showing publications co-authored by Jamil Kanji and Nathan Zelyas.
Connection Strength
0.823
-
Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance. Microbiol Spectr. 2021 09 03; 9(1):e0031521.
Score: 0.240
-
False negative rate of COVID-19 PCR testing: a discordant testing analysis. Virol J. 2021 01 09; 18(1):13.
Score: 0.231
-
Wide Variation in Threshold Cycle Values Clouds the Interpretation of SARS-CoV-2 Infectiousness. Clin Chem. 2021 12 30; 68(1):253-255.
Score: 0.062
-
Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol. BMJ Open. 2021 08 20; 11(8):e052282.
Score: 0.060
-
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic. Microbiol Spectr. 2021 09 03; 9(1):e0029121.
Score: 0.060
-
Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic. Virol J. 2021 05 01; 18(1):93.
Score: 0.059
-
Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies. J Clin Microbiol. 2020 09 22; 58(10).
Score: 0.057
-
Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020 08; 55(4):e125-e129.
Score: 0.055